Literature DB >> 22927063

Near-diploid hyperploidy in early breast cancer (T1a,b) is associated with higher risk of lymph node involvement.

Joško Bezić1, Ivana Samija-Projić, Petar Projić, Jelena Ljubković, Sandra Tomaš-Zekić, Maja Marinović-Guić, Snježana Tomić.   

Abstract

Due to the worldwide implementation of the mammographic screening program early breast cancer (T1a,b) has become more prevalent form of breast cancer. Although T1a,b breast cancers are generally associated with excellent prognosis, some of them, particularly those with lymph node involvement, has unfavourable outcome. Searching for additional prognostic factors, we investigated DNA content of 163 T1a,b cancers measured by DNA flow cytometry, and correlated it with regional lymph node status. T1a,b cancers were divided into four ploidy classes based on their DNA index (DI): hypodiploid (DI < 0.95), diploid (DI 0.95-1.05), low-hyperploid (DI 1.06-1.3), and high-hyperploid (DI > 1.3). Diploid T1a,b cancers were associated with negative lymph node status (p = 0.003). Among aneuploid cancers only low-hyperploid tumors were associated with positive lymph node status (p = 0.03). The histopathological features of low-hyperploid group of T1a,b cancers did not differ from the other three ploidy groups of cancers, except for lower S-phase fraction of tumor cells in low-hyperploid group compared to high-hyperploid group (p = 0.01). Our data showed that near-diploid hyperploid T1a,b cancers are associated with higher risk of lymph node involvement despite similar clinicopathological features shared with other ploidy classes of T1a,b tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927063     DOI: 10.1007/s12253-012-9559-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

1.  Characterization of a new cytogenetic subtype of ductal breast carcinomas.

Authors:  Romain Molist; Yorghos Remvikos; Bernard Dutrillaux; Martine Muleris
Journal:  Oncogene       Date:  2004-08-05       Impact factor: 9.867

2.  Breast cancer genetic evolution: I. Data from cytogenetics and DNA content.

Authors:  B Dutrillaux; M Gerbault-Seureau; Y Remvikos; B Zafrani; M Prieur
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

3.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

4.  Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.

Authors:  V L Ernster; J Barclay; K Kerlikowske; H Wilkie; R Ballard-Barbash
Journal:  Arch Intern Med       Date:  2000-04-10

5.  Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Authors:  S B Ewers; E Långström; B Baldetorp; D Killander
Journal:  Cytometry       Date:  1984-07

6.  Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection.

Authors:  C Zanon; A Durando; M Geuna; R Clara; A Mobiglia; M Massobrio; G Palestro; A Pourshayesteh
Journal:  Am J Clin Oncol       Date:  1998-08       Impact factor: 2.339

7.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

8.  Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.

Authors:  H Beerman; P M Kluin; J Hermans; C J van de Velde; C J Cornelisse
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

9.  Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening.

Authors:  L G Arnesson; S Smeds; G Fagerberg
Journal:  Eur J Surg       Date:  1994-05

10.  DNA aneuploidy in early breast cancer.

Authors:  G L Ottesen; I J Christensen; J K Larsen; G B Kerndrup; B Hansen; J A Andersen
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  1 in total

1.  DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy.

Authors:  Silvia Carloni; Giulia Gallerani; Anna Tesei; Emanuela Scarpi; Giorgio Maria Verdecchia; Salvatore Virzì; Francesco Fabbri; Chiara Arienti
Journal:  Onco Targets Ther       Date:  2017-09-20       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.